共 8 条
[1]
Initiating warfarin thera-py:5mg versus10mg. Eckhoff CD,Didomenico RJ,Shapiro NL. Annals of Pharmacotherapy . 2004
[2]
A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K ep-oxide reductase complex and cytochrome P4502C9. Tham LS,Goh BC,Nafziger A,et al. Clinical Pharmacology and Therapeutics . 2006
[3]
Oral vitamin K lowersthe international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy:a randomized,controlled trial. Crowther MA,Douketis JD,Schnurr T,et al. Annals of Internal Medicine . 2002
[4]
Antithrombotic therapy in valvular heart disease-native and prosthetic:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Salem DN,Stein PD,Al-Ahmad A,et al. Chest . 2004
[5]
Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin-K dependent clotting factors. Zivelin A,Rao LV,Rapaport SI. The Journal of Clinical Investigation . 1993
[6]
Oral anticoagulant therapy in patients with cor-onary artery disease:a meta-analysis. Anand SS,Yusuf S. The Journal of The American Medical Association . 1999
[8]
Optimal oral anticoagulant therapy in patients with mechanical heart valve pros-theses:the Leiden artificial valve and anticoagulation study. Cannegieter SC,Rosendaal FR,Wintzen AR,et al. The New England Journal of Medicine . 1995